Afya (AFYA) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

AFYA Stock Forecast


Afya stock forecast is as follows: an average price target of $18.50 (represents a 14.55% upside from AFYA’s last price of $16.15) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.

AFYA Price Target


The average price target for Afya (AFYA) is $18.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $19.00 to $18.00. This represents a potential 14.55% upside from AFYA's last price of $16.15.

AFYA Analyst Ratings


Hold

According to 3 Wall Street analysts, Afya's rating consensus is 'Hold'. The analyst rating breakdown for AFYA stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 2 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Afya Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 21, 2024Mauricio CepedaMorgan Stanley$19.00$16.6114.39%17.65%
Nov 22, 2022-Credit Suisse$18.00$14.5923.41%11.46%
Row per page
Go to

The latest Afya stock forecast, released on Jun 21, 2024 by Mauricio Cepeda from Morgan Stanley, set a price target of $19.00, which represents a 14.39% increase from the stock price at the time of the forecast ($16.61), and a 17.65% increase from AFYA last price ($16.15).

Afya Price Target by Period


1M3M12M
# Anlaysts-11
Avg Price Target-$19.00$19.00
Last Closing Price$16.15$16.15$16.15
Upside/Downside-100.00%17.65%17.65%

In the current month, the average price target of Afya stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Afya's last price of $16.15. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 30, 2024UBS-NeutralInitialise
Jun 21, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Oct 13, 2023Morgan Stanley-OverweightUpgrade
Nov 22, 2022Credit SuisseOutperformOutperformHold
Row per page
Go to

Afya's last stock rating was published by UBS on Aug 30, 2024. The company Initialise its AFYA rating from "null" to "Neutral".

Afya Financial Forecast


Afya Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue---------------$709.96M$584.00M$580.58M$598.16M$566.32M$498.26M$454.39M$372.37M$394.35M$345.27M$309.41M$274.21M$272.30M$220.85M$206.71M
Avg Forecast$939.09M$935.47M$916.30M$902.01M$844.60M$842.14M$817.48M$805.14M$732.16M$827.02M$802.10M$794.83M$698.90M$715.42M$698.32M$680.36M$609.58M$570.16M$543.67M$564.25M$506.83M$442.61M$379.56M$394.45M$338.33M$309.45M$248.14M$275.63M$209.37M$198.99M
High Forecast$956.72M$953.03M$933.50M$918.94M$860.46M$857.95M$832.83M$820.26M$745.91M$842.55M$817.16M$809.75M$712.02M$728.85M$711.43M$693.13M$621.02M$580.86M$543.67M$564.25M$506.83M$442.61M$379.56M$394.45M$338.33M$309.45M$248.14M$275.63M$209.37M$198.99M
Low Forecast$925.78M$922.20M$903.31M$889.22M$832.63M$830.20M$805.89M$793.73M$721.78M$815.29M$790.73M$783.56M$688.99M$705.27M$688.42M$670.71M$600.94M$562.08M$543.67M$564.25M$506.83M$442.61M$379.56M$394.45M$338.33M$309.45M$248.14M$275.63M$209.37M$198.99M
# Analysts1111----12112111--------------
Surprise %---------------1.04%0.96%1.02%1.10%1.00%0.98%1.03%0.98%1.00%1.02%1.00%1.11%0.99%1.05%1.04%

Afya's average Quarter revenue forecast for Jun 23 based on 1 analysts is $698.32M, with a low forecast of $688.42M, and a high forecast of $711.43M. AFYA's average Quarter revenue forecast represents a -1.64% decrease compared to the company's last Quarter revenue of $709.96M (Mar 23).

Afya EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111----12112111--------------
EBITDA---------------$289.36M$194.90M$195.26M$217.63M$248.56M$174.59M$154.64M$95.24M$173.82M$119.46M$122.81M$109.17M$149.68M$77.28M$98.86M
Avg Forecast$354.77M$353.40M$346.16M$340.76M$319.08M$318.15M$308.83M$304.17M$276.60M$312.43M$303.02M$300.27M$264.03M$270.27M$263.81M$257.03M$230.29M$215.40M$205.39M$208.81M$187.56M$163.80M$140.47M$145.97M$125.20M$114.52M$91.83M$102.00M$77.48M$73.64M
High Forecast$361.43M$360.04M$352.66M$347.16M$325.07M$324.12M$314.63M$309.88M$281.79M$318.30M$308.71M$305.91M$268.99M$275.35M$268.76M$261.85M$234.61M$219.44M$205.39M$208.81M$187.56M$163.80M$140.47M$145.97M$125.20M$114.52M$91.83M$102.00M$77.48M$73.64M
Low Forecast$349.74M$348.39M$341.25M$335.93M$314.55M$313.63M$304.45M$299.86M$272.68M$308.00M$298.72M$296.01M$260.29M$266.44M$260.07M$253.38M$227.02M$212.34M$205.39M$208.81M$187.56M$163.80M$140.47M$145.97M$125.20M$114.52M$91.83M$102.00M$77.48M$73.64M
Surprise %---------------1.13%0.85%0.91%1.06%1.19%0.93%0.94%0.68%1.19%0.95%1.07%1.19%1.47%1.00%1.34%

1 analysts predict AFYA's average Quarter EBITDA for Jun 23 to be $263.81M, with a high of $268.76M and a low of $260.07M. This is -8.83% lower than Afya's previous annual EBITDA (Mar 23) of $289.36M.

Afya Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111----12112111--------------
Net Income---------------$112.12M$66.69M$75.76M$101.50M$129.61M$49.00M$53.03M$17.24M$108.09M$56.75M$74.83M$60.68M$99.82M$49.80M$46.27M
Avg Forecast$179.95M$212.19M$213.88M$263.96M$169.97M$195.55M$196.74M$241.03M$142.73M$174.93M$177.01M$219.52M$142.87M$123.65M$118.57M$144.26M$129.98M$326.56M$95.67M$481.00M$78.07M$300.73M$144.30M$773.88M$128.51M$101.03M$216.87M$398.97M$87.81M$52.51M
High Forecast$184.34M$217.37M$219.10M$270.40M$174.12M$200.32M$201.54M$246.92M$146.21M$179.20M$181.33M$224.87M$146.35M$126.67M$121.46M$147.78M$133.15M$391.87M$95.67M$577.20M$78.07M$360.87M$173.16M$928.65M$128.51M$101.03M$260.25M$478.77M$87.81M$52.51M
Low Forecast$176.63M$208.28M$209.94M$259.09M$166.84M$191.94M$193.11M$236.59M$140.10M$171.71M$173.74M$215.47M$140.23M$121.37M$116.38M$141.60M$127.58M$261.25M$95.67M$384.80M$78.07M$240.58M$115.44M$619.10M$128.51M$101.03M$173.50M$319.18M$87.81M$52.51M
Surprise %---------------0.78%0.51%0.23%1.06%0.27%0.63%0.18%0.12%0.14%0.44%0.74%0.28%0.25%0.57%0.88%

Afya's average Quarter net income forecast for Jun 23 is $118.57M, with a range of $116.38M to $121.46M. AFYA's average Quarter net income forecast represents a 5.75% increase compared to the company's last Quarter net income of $112.12M (Mar 23).

Afya SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111----12112111--------------
SG&A---------------$233.22M$201.53M$210.69M$207.41M$178.51M$178.22M$178.81M$135.18M$130.40M$121.38M$104.72M$90.04M$86.72M$77.04M$71.26M
Avg Forecast$321.47M$320.22M$313.66M$308.77M$289.12M$288.28M$279.84M$275.61M$250.63M$283.10M$274.57M$272.08M$239.24M$244.90M$239.04M$232.90M$208.67M$195.17M$186.11M$177.00M$158.99M$138.84M$119.07M$123.74M$106.13M$97.07M$77.84M$86.46M$65.68M$62.42M
High Forecast$327.50M$326.24M$319.55M$314.57M$294.55M$293.69M$285.09M$280.79M$255.33M$288.42M$279.73M$277.19M$243.73M$249.49M$243.53M$237.27M$212.58M$198.84M$186.11M$177.00M$158.99M$138.84M$119.07M$123.74M$106.13M$97.07M$77.84M$86.46M$65.68M$62.42M
Low Forecast$316.91M$315.68M$309.22M$304.39M$285.02M$284.19M$275.87M$271.70M$247.08M$279.09M$270.68M$268.22M$235.85M$241.43M$235.65M$229.60M$205.71M$192.41M$186.11M$177.00M$158.99M$138.84M$119.07M$123.74M$106.13M$97.07M$77.84M$86.46M$65.68M$62.42M
Surprise %---------------1.00%0.97%1.08%1.11%1.01%1.12%1.29%1.14%1.05%1.14%1.08%1.16%1.00%1.17%1.14%

Afya's average Quarter SG&A projection for Jun 23 is $239.04M, based on 1 Wall Street analysts, with a range of $235.65M to $243.53M. The forecast indicates a 2.50% rise compared to AFYA last annual SG&A of $233.22M (Mar 23).

Afya EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111----12112111--------------
EPS---------------$1.25$0.74$0.84$1.12$1.42$0.52$0.57$0.18$1.16$0.61$0.80$0.65$1.09$0.54$0.54
Avg Forecast$1.97$2.33$2.35$2.90$1.86$2.14$2.16$2.64$1.57$1.92$1.94$2.41$1.57$1.36$1.30$1.58$1.43$1.36$0.98$1.60$0.86$0.95$1.08$1.48$1.42$1.11$0.71$1.14$0.97$0.58
High Forecast$2.02$2.38$2.40$2.97$1.91$2.20$2.21$2.71$1.60$1.97$1.99$2.47$1.61$1.39$1.33$1.62$1.46$1.39$0.98$1.60$0.86$0.95$1.08$1.48$1.42$1.11$0.71$1.14$0.97$0.58
Low Forecast$1.94$2.28$2.30$2.84$1.83$2.11$2.12$2.60$1.54$1.88$1.91$2.36$1.54$1.33$1.28$1.55$1.40$1.33$0.98$1.60$0.86$0.95$1.08$1.48$1.42$1.11$0.71$1.14$0.97$0.58
Surprise %---------------0.79%0.52%0.62%1.14%0.89%0.60%0.60%0.17%0.78%0.43%0.72%0.91%0.96%0.56%0.93%

According to 1 Wall Street analysts, Afya's projected average Quarter EPS for Jun 23 is $1.30, with a low estimate of $1.28 and a high estimate of $1.33. This represents a 4.04% increase compared to AFYA previous annual EPS of $1.25 (Mar 23).

Afya Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
STRAStrategic Education$92.25$127.5038.21%Buy
LINCLincoln Educational Services$11.41$14.6728.57%Buy
LOPEGrand Canyon Education$137.41$162.0017.90%Buy
AFYAAfya$16.15$18.5014.55%Hold
APEIAmerican Public Education$14.83$15.504.52%Buy
LRNStride$79.49$66.75-16.03%Buy
ATGEAdtalem Global Education$69.79$49.80-28.64%Buy

AFYA Forecast FAQ


No, according to 3 Wall Street analysts, Afya (AFYA) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 33.33% of AFYA's total ratings.

Afya (AFYA) average price target is $18.5 with a range of $18 to $19, implying a 14.55% from its last price of $16.15. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for AFYA stock, the company can go up by 14.55% (from the last price of $16.15 to the average price target of $18.5), up by 17.65% based on the highest stock price target, and up by 11.46% based on the lowest stock price target.

AFYA's average twelve months analyst stock price target of $18.5 does not support the claim that Afya can reach $20 in the near future.

Afya's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $3.31B (high $3.37B, low $3.26B), average EBITDA is $1.25B (high $1.27B, low $1.23B), average net income is $803.29M (high $822.89M, low $788.48M), average SG&A $1.13B (high $1.15B, low $1.12B), and average EPS is $8.81 (high $9.03, low $8.65). AFYA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.69B (high $3.76B, low $3.64B), average EBITDA is $1.4B (high $1.42B, low $1.38B), average net income is $869.98M (high $891.21M, low $853.94M), average SG&A $1.26B (high $1.29B, low $1.25B), and average EPS is $9.54 (high $9.78, low $9.37).

Based on Afya's last annual report (Dec 2022), the company's revenue was $2.33B, beating the average analysts forecast of $2.29B by 1.81%. Apple's EBITDA was $856.35M, missing the average prediction of $859.88M by -0.41%. The company's net income was $373.57M, missing the average estimation of $1.03B by -63.84%. Apple's SG&A was $798.15M, beating the average forecast of $766.95M by 4.07%. Lastly, the company's EPS was $4.15, missing the average prediction of $5.37 by -22.69%. In terms of the last quarterly report (Mar 2023), Afya's revenue was $709.96M, beating the average analysts' forecast of $680.36M by 4.35%. The company's EBITDA was $289.36M, beating the average prediction of $257.03M by 12.58%. Afya's net income was $112.12M, missing the average estimation of $144.26M by -22.28%. The company's SG&A was $233.22M, beating the average forecast of $232.9M by 0.14%. Lastly, the company's EPS was $1.25, missing the average prediction of $1.58 by -21.01%